News for Vericel Corporation (VCEL)

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (VCEL), a leader in advanced therapies for the sports medicine and severe burn care m

Full-Year Total Revenue Growth of 20% to $237.2 Million, with MACI Revenue Growth of 20% and Burn Care Revenue Growth of 22% Full-Year Adjusted EBITDA Growth o

Vericel (VCEL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

The Dow Jones Industrial Average soared 700 points after inflation cooled in December. Nvidia rebounded in the stock market today.

The Dow Jones Industrial Average soared 600 points after inflation cooled in December. Nvidia rebounded in the stock market today.

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Wednesday. Shares of Applied Digital Corporation APLD fell sha...

Full-Year 2024 Total Revenue Growth of 20% and Adjusted EBITDA Growth of Approximately 55% MACI Full-Year 2024 Revenue Growth of 20%, with Fourth Quarter Reven

Vericel Corporation (VCEL) expects strong revenue growth in 2024 and 2025, with gross margin and EBITDA margin also showing positive trends.

**media[515144]**

Vericel's preliminary Q4 revenue falls short of analyst expectations; shares fall 11% post market

**media[509425]**

Vericel Corporation, specializing in cellular therapies for sports medicine and severe burn care, has seen a 40% rise in its stock recently. Click for more on VCEL.

**media[477627,477628]**

**media[476518]**

Total Revenue Growth of 27% to $57.9 Million Gross Margin of 72% and Adjusted EBITDA Growth of 84% Full-Year Profitability Guidance Raised FDA Approval...

Advancements and Projections in the Global Degenerative Disc Disease Treatment Market: Insights, Trends, Opportunities, and Recent Developments...

With an impressive 22.55% CAGR, global cell therapy market is poised for exponential growth, fueled by cutting-edge technologies, regulatory approvals, and...

Autologous Cell Therapy Breakthroughs in Cancer and Autoimmune Disease Treatment...

The Global Regenerative Medicine Market Size is projected to grow at a CAGR of 23.19% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 32.71 Billion in 2024 and is expected to reach USD 173.49…